Risk stratification with the use of serial N-terminal Pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: Post hoc analysis of the PRIMA study

Journal of Cardiac Failure

Volumn 20, Issue 12, 2014, Pages 881-890

  Eurlings, Luc W ^a   Sanders Van Wijk, Sandra ^a   Van Kraaij, Dave J W ^b   Van Kimmenade, Roland ^a,c   Meeder, Joan G ^d   Kamp, Otto ^e   Van Dieijen Visser, Marja P ^f   Tijssen, Jan G P ^g   Brunner La Rocca, Hans Peter ^a   Pinto, Yigal M ^g  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Zuyderland Medical Centre   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VIECURI MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

heart failure; NT proBNP; risk stratification; serial measurements

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL EVALUATION; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; AGE; ANALYSIS OF VARIANCE; BLOOD; CAUSE OF DEATH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; HEART FAILURE; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; SURVIVAL; TRENDS; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CAUSE OF DEATH; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PATIENT ADMISSION; PATIENT DISCHARGE; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 84920052068     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.08.014     Document Type: Article

References (26)

1. M.S. Nieminen, D. Brutsaert, K. Dickstein, H. Drexler, F. Follath, and V.P. Harjola Euroheart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur Heart J 27 2006 2725 2736
2. V.P. Harjola, F. Follath, M.S. Nieminen, D. Brutsaert, K. Dickstein, and H. Drexler Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure Eur J Heart Fail 12 2010 239 248
3. S. Stewart, K. MacIntyre, D.J. Hole, S. Capewell, and J.J. McMurray More 'malignant' than cancer? Five-year survival following a first admission for heart failure Eur J Heart Fail 3 2001 315 322
4. P. Bettencourt, A. Azevedo, J. Pimenta, F. Frioes, S. Ferreira, and A. Ferreira N-Terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2004 2168 2174
5. R.J. O'Brien, I.B. Squire, B. Demme, J.E. Davies, and L.L. Ng Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF Eur J Heart Fail 5 2003 499 506
6. S. Masson, R. Latini, I.S. Anand, S. Barlera, L. Angelici, and T. Vago Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial) J Am Coll Cardiol 52 2008 997 1003
7. S. Bruins, M.R. Fokkema, J.W. Romer, M.J. Dejongste, F.P. van der Dijs, and J.M. van den Ouweland High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure Clin Chem 50 2004 2052 2058
8. L.W. Eurlings, P.E. van Pol, W.E. Kok, S. van Wijk, C. Lodewijks-van der Bolt, and A.H. Balk Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can Pro-Brain-Natriuretic Peptide Guided Therapy of Chronic Heart Failure Improve Heart Failure Morbidity and Mortality?) study J Am Coll Cardiol 56 2010 2090 2100
9. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth Modification of Diet in Renal Disease Study Group A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 1999 461 470
10. G.C. Fonarow, W.F. Peacock, C.O. Phillips, M.M. Givertz, and M. Lopatin Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure J Am Coll Cardiol 49 2007 1943 1950
11. P. Kubler, E.A. Jankowska, J. Majda, K. Reczuch, W. Banasiak, and P. Ponikowski Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome Int J Cardiol 129 2008 373 378
12. F. Knebel, I. Schimke, I. Diaz Ramirez, S. Schattke, S. Eddicks, and A.C. Borges Hemodynamic improvement of acutely decompensated heart failure patients is associated with decreasing levels of NT-proBNP Int J Cardiol 134 2009 260 263
13. D. Moertl, A. Hammer, M. Huelsmann, R. Pacher, and R. Berger Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patients Eur J Heart Fail 10 2008 404 411
14. A. Bayes-Genis, D. Pascual-Figal, J. Fabregat, M. Domingo, F. Planas, and T. Casas Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure Int J Cardiol 120 2007 338 343
15. J.P. Araujo, A. Azevedo, P. Lourenco, F. Rocha-Goncalves, A. Ferreira, and P. Bettencourt Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure Am J Cardiol 98 2006 1248 1250
16. L. Frankenstein, A. Remppis, J. Frankenstein, G. Hess, D. Zdunek, and K. Slottje Variability of N-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables Clin Chem 55 2009 923 929
17. R. O'Hanlon, P. O'Shea, M. Ledwidge, C. O'Loughlin, S. Lange, and C. Conlon The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients J Card Fail 13 2007 50 55
18. M. Schou, F. Gustafsson, A. Kjaer, and P.R. Hildebrandt Long-term clinical variation of NT-proBNP in stable chronic heart failure patients Eur Heart J 28 2007 177 182
19. M. Schou, F. Gustafsson, P.H. Nielsen, L.H. Madsen, A. Kjaer, and P.R. Hildebrandt Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state Eur J Heart Fail 9 2007 68 74
20. R. Berger, D. Moertl, S. Peter, R. Ahmadi, M. Huelsmann, and S. Yamuti N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study J Am Coll Cardiol 55 2010 645 653
21. J.G. Lainchbury, R.W. Troughton, and K.M. Strangman N-Terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death) trial J Am Coll Cardiol 55 2009 53 60
22. J.L. Januzzi Jr., S.U. Rehman, A.A. Mohammed, C.M. Frampton, A. Pilbrow, and T.G. Yandle Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol 58 2011 1881 1889
23. P. Jourdain, G. Jondeau, F. Funck, P. Gueffet, A. Le Helloco, and E. Donal Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP multicenter study J Am Coll Cardiol 49 2007 1733 1739
24. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
25. G.M. Felker, C.M. O'Connor, and E. Braunwald Loop diuretics in acute decompensated heart failure: necessary? evil? a necessary evil? Circ Heart Fail 2 2009 56 62
26. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, and K. Dickstein ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847